DOCSLIB.ORG

Title 21–Food and Drugs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Title 21–Food and Drugs Title 21–Food and Drugs (This book contains part 1300 to end) Part CHAPTER II—Drug Enforcement Administration, Depart- ment of Justice .................................................................. 1300 CHAPTER III—Office of National Drug Control Policy ............ 1401 1 VerDate Sep<11>2014 10:58 Jul 14, 2020 Jkt 250078 PO 00000 Frm 00011 Fmt 8008 Sfmt 8008 Y:\SGML\250078.XXX 250078 rmajette on DSKBCKNHB2PROD with CFR VerDate Sep<11>2014 10:58 Jul 14, 2020 Jkt 250078 PO 00000 Frm 00012 Fmt 8008 Sfmt 8008 Y:\SGML\250078.XXX 250078 rmajette on DSKBCKNHB2PROD with CFR CHAPTER II—DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE Part Page 1300 Definitions .............................................................. 5 1301 Registration of manufacturers, distributors, and dispensers of controlled substances ..................... 23 1302 Labeling and packaging requirements for con- trolled substances ................................................ 58 1303 Quotas ..................................................................... 60 1304 Records and reports of registrants .......................... 69 1305 Orders for schedule I and II controlled substances 89 1306 Prescriptions ........................................................... 100 1307 Miscellaneous .......................................................... 112 1308 Schedules of controlled substances ......................... 114 1309 Registration of manufacturers, distributors, im- porters and exporters of list I chemicals .............. 142 1310 Records and reports of listed chemicals and certain machines; importation and exportation of cer- tain machines ....................................................... 153 1311 Requirements for electronic orders and prescrip- tions ..................................................................... 180 1312 Importation and exportation of controlled sub- stances ................................................................. 200 1313 Importation and exportation of list I and list II chemicals ............................................................. 224 1314 Retail sale of scheduled listed chemical products ... 237 1315 Importation and production quotas for ephedrine, pseudoephedrine, and phenylpropanolamine ........ 245 1316 Administrative functions, practices, and proce- dures ..................................................................... 256 1317 Disposal ................................................................... 269 1321 DEA Mailing addresses ............................................ 278 1322–1399 [Reserved] 3 VerDate Sep<11>2014 10:58 Jul 14, 2020 Jkt 250078 PO 00000 Frm 00013 Fmt 8008 Sfmt 8008 Y:\SGML\250078.XXX 250078 rmajette on DSKBCKNHB2PROD with CFR VerDate Sep<11>2014 10:58 Jul 14, 2020 Jkt 250078 PO 00000 Frm 00014 Fmt 8008 Sfmt 8008 Y:\SGML\250078.XXX 250078 rmajette on DSKBCKNHB2PROD with CFR PART 1300—DEFINITIONS (7) 5-androstenediol (3b,17b-dihydroxy- androst-5-ene) Sec. (8) 1-androstenedione ([5a]-androst-1- 1300.01 Definitions relating to controlled en-3,17-dione) substances. (9) 4-androstenedione (androst-4-en- 1300.02 Definitions relating to listed chemi- 3,17-dione) cals. (10) 5-androstenedione (androst-5-en- 1300.03 Definitions relating to electronic or- 3,17-dione) ders for controlled substances and elec- tronic prescriptions for controlled sub- (11) bolasterone (7a,17a-dimethyl-17b- stances. hydroxyandrost-4-en-3-one) 1300.04 Definitions relating to the dis- (12) boldenone (17b-hydroxyandrost-1,4- pensing of controlled substances by diene-3-one) means of the Internet. (13) boldione (androsta-1,4-diene-3,17- 1300.05 Definitions relating to the disposal dione) of controlled substances. (14) calusterone (7b,17a-dimethyl-17b- AUTHORITY: 21 U.S.C. 802, 821, 822, 829, hydroxyandrost-4-en-3-one) 871(b), 951, 958(f). (15) clostebol (4-chloro-17b- SOURCE: 62 FR 13941, Mar. 24, 1997, unless hydroxyandrost-4-en-3-one) otherwise noted. (16) dehydrochloromethyltestosterone (4-chloro-17b-hydroxy-17a-methyl- § 1300.01 Definitions relating to con- androst-1,4-dien-3-one) trolled substances. (17) desoxymethyltestosterone (17a- (a) Any term not defined in this part methyl-5a-androst-2-en-17b-ol) shall have the definition set forth in (a.k.a. ‘madol‘) section 102 of the Act (21 U.S.C. 802), (18) D1-dihydrotestosterone (a.k.a.‘1- except that certain terms used in part testosterone‘) (17b-hydroxy-5a- 1316 of this chapter are defined at the androst-1-en-3-one) beginning of each subpart of that part. (19) 4-dihydrotestosterone (17b-hy- (b) As used in parts 1301 through 1308, droxy-androstan-3-one) 1312, and 1317 of this chapter, the fol- (20) drostanolone (17b-hydroxy-2a- lowing terms shall have the meanings methyl-5a-androstan-3-one) specified: (21) ethylestrenol (17a-ethyl-17b- Act means the Controlled Substances hydroxyestr-4-ene) Act, as amended (84 Stat. 1242; 21 U.S.C. (22) fluoxymesterone (9-fluoro-17a- 801) and/or the Controlled Substances methyl-11b,17b-dihydroxyandrost-4- Import and Export Act, as amended (84 en-3-one) Stat. 1285; 21 U.S.C. 951). (23) formebolone (2-formyl-17a-methyl- Administration means the Drug En- 11a,17b-dihydroxyandrost-1,4-dien-3- forcement Administration. one) Administrator means the Adminis- (24) furazabol (17a-methyl-17b- trator of the Drug Enforcement Admin- hydroxyandrostano[2,3-c]-furazan) istration. The Administrator has been (25) 13b-ethyl-17b-hydroxygon-4-en-3- delegated authority under the Act by one the Attorney General (28 CFR 0.100). (26) 4-hydroxytestosterone (4,17b- Anabolic steroid means any drug or dihydroxy-androst-4-en-3-one) hormonal substance, chemically and (27) 4-hydroxy-19-nortestosterone pharmacologically related to testos- (4,17b-dihydroxy-estr-4-en-3-one) terone (other than estrogens, (28) mestanolone (17a-methyl-17b-hy- progestins, corticosteroids, and droxy-5-androstan-3-one) dehydroepiandrosterone), and includes: (29) mesterolone (1a-methyl-17b-hy- (1) 3b,17-dihydroxy-5a-androstane droxy-[5a]-androstan-3-one) (2) 3a,17b-dihydroxy-5a-androstane (30) methandienone (17a-methyl-17b- (3) 5a-androstan-3,17-dione hydroxyandrost-1,4-dien-3-one) (4) 1-androstenediol (3b,17b-dihydroxy- (31) methandriol (17a-methyl-3b,17b- 5a-androst-1-ene) dihydroxyandrost-5-ene) (5) 1-androstenediol (3a,17b-dihydroxy- (32) Methasterone (2a,17a-dimethyl-5a- 5a-androst-1-ene) androstan-17b-ol-3-one) (6) 4-androstenediol (3b,17b-dihydroxy- (33) methenolone (1-methyl-17b-hy- androst-4-ene) droxy-5a-androst-1-en-3-one) 5 VerDate Sep<11>2014 10:58 Jul 14, 2020 Jkt 250078 PO 00000 Frm 00015 Fmt 8010 Sfmt 8010 Y:\SGML\250078.XXX 250078 rmajette on DSKBCKNHB2PROD with CFR § 1300.01 21 CFR Ch. II (4–1–20 Edition) (34) 17a-methyl-3b,17b-dihydroxy-5a-an- (61) testolactone (13-hydroxy-3-oxo- drostane 13,17-secoandrosta-1,4-dien-17-oic (35) 17a-methyl-3a,17b-dihydroxy-5a-an- acid lactone) drostane (62) testosterone (17b-hydroxyandrost- (36) 17a-methyl-3b,17b- 4-en-3-one) dihydroxyandrost-4-ene (63) tetrahydrogestrinone (13b, 17a- (37) 17a-methyl-4-hydroxynandrolone diethyl-17b-hydroxygon-4,9,11-trien- (17a-methyl-4-hydroxy-17b- 3-one) hydroxyestr-4-en-3-one) (64) trenbolone (17b-hydroxyestr-4,9,11- (38) methyldienolone (17a-methyl-17b- trien-3-one) hydroxyestra-4,9(10)-dien-3-one) (65) Any salt, ester, or ether of a drug (39) methyltrienolone (17a-methyl-17b- or substance described in this para- hydroxyestra-4,9,11-trien-3-one) graph. Except such term does not (40) methyltestosterone (17a-methyl- include an anabolic steroid that is 17b-hydroxyandrost-4-en-3-one) expressly intended for administra- (41) mibolerone (7a,17a-dimethyl-17b- tion through implants to cattle or hydroxyestr-4-en-3-one) other nonhuman species and that (42) 17a-methyl-D1-dihydrotestosterone has been approved by the Secretary (17b-hydroxy-17a-methyl-5a- of Health and Human Services for androst-1-en-3-one) (a.k.a. ‘17-a- such administration. If any person methyl-1-testosterone‘) prescribes, dispenses, or distributes (43) nandrolone (17b-hydroxyestr-4-en-3- such steroid for human use, the one) person shall be considered to have (44) 19-nor-4-androstenediol (3b, 17b- prescribed, dispensed, or distrib- dihydroxyestr-4-ene) uted an anabolic steroid within the (45) 19-nor-4-androstenediol (3a, 17b- meaning of this paragraph. dihydroxyestr-4-ene) Automated dispensing system means a (46) 19-nor-5-androstenediol (3b, 17b- mechanical system that performs oper- dihydroxyestr-5-ene) ations or activities, other than (47) 19-nor-5-androstenediol (3a, 17b- compounding or administration, rel- dihydroxyestr-5-ene) ative to the storage, packaging, count- (48) 19-nor-4,9(10)-androstadienedione ing, labeling, and dispensing of medica- (estra-4,9(10)-diene-3,17-dione) tions, and which collects, controls, and (49) 19-nor-4-androstenedione (estr-4-en- maintains all transaction information. 3,17-dione) Basic class means, as to controlled (50) 19-nor-5-androstenedione (estr-5-en- substances listed in Schedules I and II: 3,17-dione) (1) Each of the opiates, including its (51) norbolethone (13b, 17a-diethyl-17b- isomers, esters, ethers, salts, and salts hydroxygon-4-en-3-one) of isomers, esters, and ethers whenever (52) norclostebol (4-chloro-17b- the existence of such isomers, esters, hydroxyestr-4-en-3-one) ethers, and salts is possible within the (53) norethandrolone (17a-ethyl-17b- specific chemical designation, listed in hydroxyestr-4-en-3-one) § 1308.11(b) of this chapter; (54) normethandrolone (17a-methyl-17b- (2) Each of the opium derivatives, in- hydroxyestr-4-en-3-one) cluding its salts, isomers, and
Load more

Recommended publications
  • Cocaine: Pharmacology, Effects, and Treatment of Abuse
    Cocaine: Pharmacology, Effects, and Treatment of Abuse U. S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol, Drug Abuse, and Mental Health Administration Cocaine: Pharmacology, Effects, and Treatment of Abuse Editor: John Grabowski, Ph.D. Division of Clinical Research National Institute on Drug Abuse NIDA Research Monograph 50 1984 DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, Maryland 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, D.C. 20402 NIDA Research Monographs are prepared by the research divisions of the National Institute on Drug Abuse and published by its Office of Science The primary objective of the series is to provide critical reviews of research problem areas and techniques, the content of state-of-the-art conferences, and integrative research reviews. Its dual publication emphasis is rapid and targeted dissemination to the scientific and professional community. Editorial Advisors MARTIN W. ADLER, Ph.D. SIDNEY, COHEN M.D. Temple University School of Medicine LosAngeles, California Philadelphia, Pennsylvania SYDNEY ARCHER, Ph.D. MARY L. JACOBSON Rensselaer Polytechnic Institute National Federation of Parents for Troy, New York Drug Free Youth RICHARD BELLEVILLE, Ph.D. Omaha, Nebraska NB Associates, Health Sciences Rockville, Maryland REESE T. JONES, M.D. KARST J. BESTMAN Langley Porter Neuropsychiatric Institute San Francisco, California Alcohol and Drug Problems Association of North America Washington, D.C. DENISE KANDEL, Ph.D. GILBERT J. BOVTIN, Ph.D. College of Physicians and Surgeons of Cornell University Medical College Columbia University New York, New York New York, New York JOSEPH V.
    [Show full text]
  • List of Narcotic Drugs Under International Control
    International Narcotics Control Board Yellow List Annex to Forms A, B and C 59th edition, July 2020 LIST OF NARCOTIC DRUGS UNDER INTERNATIONAL CONTROL Prepared by the INTERNATIONAL NARCOTICS CONTROL BOARD* Vienna International Centre P.O. Box 500 A-1400 Vienna, Austria Internet address: http://www.incb.org/ in accordance with the Single Convention on Narcotic Drugs, 1961** Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 * On 2 March 1968, this organ took over the functions of the Permanent Central Narcotics Board and the Drug Supervisory Body, r etaining the same secretariat and offices. ** Subsequently referred to as “1961 Convention”. V.20-03697 (E) *2003697* Purpose The Yellow List contains the current list of narcotic drugs under international control and additional relevant information. It has been prepared by the International Narcotics Control Board to assist Governments in completing the annual statistical reports on narcotic drugs (Form C), the quarterly statistics of imports and exports of narcotic drugs (Form A) and the estimates of annual requirements for narcotic drugs (Form B) as well as related questionnaires. The Yellow List is divided into four parts: Part 1 provides a list of narcotic drugs under international control in the form of tables and is subdivided into three sections: (1) the first section includes the narcotic drugs listed in Schedule I of the 1961 Convention as well as intermediate opiate raw materials; (2) the second section includes the narcotic drugs listed in Schedule II of the 1961 Convention; and (3) the third section includes the narcotic drugs listed in Schedule IV of the 1961 Convention.
    [Show full text]
  • Recommended Methods for the Identification and Analysis of Cocaine in Seized Materials
    Recommended methods for the Identification and Analysis of Cocaine in Seized Materials MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Photo credits: UNODC Photo Library; UNODC/Ioulia Kondratovitch; Alessandro Scotti. Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Cocaine in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS New York, 2012 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases, but any modification has to be validated before it is integrated into laboratory routines. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. ST/NAR/7/REV.1 Original language: English © United Nations, March 2012. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. ii Contents Page 1. Introduction ................................................. 1 1.1 Background .............................................. 1 1.2 Purpose and use of the manual .............................. 1 2. Physical appearance and chemical characteristics of coca leaf and illicit materials containing cocaine ................................
    [Show full text]
  • Fate and Removal of Emerging Contaminants in Water and Wastewater Treatment Plants
    FATE AND REMOVAL OF EMERGING CONTAMINANTS IN WATER AND WASTEWATER TREATMENT PLANTS Faculty of Industrial Engineering Department of Civil, Constructional and Environmental Engineering Ph.D. School of Civil Engineering and Architecture Ph.D. Course in Environmental and Hydraulic Engineering - XXXII Cycle Ph.D. student Ing. Camilla Di Marcantonio Supervisor Co-Supervisor Prof. Agostina Chiavola Prof. Maria Rosaria Boni Abstract Abstract Organic MicroPollutants (OMPs) – also called Emerging Contaminants or Contaminants of Emerging Concern – include a wide number of chemicals belonging to different classes, e.g. pharmaceuticals and personal care products (PPCPs), drugs of abuse and their metabolites, steroids and hormones, endocrine- disrupting compounds, surfactants, perfluorinated compounds, phosphoric ester flame retardants, industrial additives and agents, siloxanes, artificial sweeteners, and gasoline additives (Barbosa et al., 2016; Bletsou et al., 2015; Chiavola et al., 2019). In the last two decades, increasing attention has been dedicated to OMPs, as a matter of high risk for public health and environment. (Naidu et al., 2016; Rodriguez-Narvaez et al., 2017; Thomaidi et al., 2016; Vilardi et al., 2017). OMPs are characterized by low environmental concentrations (about ng/L or µg/L), high toxicity, very low biodegradability and resistance to degradation and to conventional treatments. Consequently, they tend to be bioaccumulated in aquatic environments, and to enter the food chain through agriculture products and drinking water (Clarke and Smith, 2011). Measurement of OMPs in the aquatic medium became possible only in the last 20 years, thanks to the improvement of sensitivity and accuracy of the analytical methods; among the different methods, liquid chromatography coupled with high-resolution tandem mass spectrometry (LC-HRMS/MS) is increasingly applied for the analysis of some known and unknown emerging contaminants in water.
    [Show full text]
  • Screening Colour Test and Specific Colour Tests for the Detection of Methylendioxyamphetamine and Amphetamine Type Stimulants
    SCIENTIFIC AND TECHNICAL NOTES SCITEC 16 2009 Screening Colour Test and Specific Colour Tests for the Detection of Methylendioxyamphetamine and Amphetamine Type Stimulants Laboratory and Scientific Section, Division of Policy Analysis 1. Introduction The term amphetamine type stimulants (ATS) refer to a range of drugs mostly derived from the phenethylamines. Amphetamines are central nervous system (CNS) stimulants that were first synthesised more than a century ago for medical applications, but are currently mostly found on illicit drug markets. Globally, ATS use occurs in a range of contexts, and for a variety of purposes. Both recreational and occupational reasons may determine initial use; and use may occur in public settings (e.g., nightclubs), private parties, work environments or as sex aids. In this respect, ATS have demonstrated their attractiveness in a very wide range of situations that seem to differ across countries. ATS are used recreationally to experience the drug’s effects of increased sociability, loss of inhibitions, a sense of escape, or to enhance sexual encounters30‐34. In many high income countries, users typically have a history of other drug use and may use other substances in combination with M/A35‐38. M/A is sometimes used in occupational settings to sustain long work hours and to increase energy and productivity. Examples of this include use by jade‐mine workers in Myanmar, sex workers in Cambodia (Chouvy & Meissonnier, 2004), truck drivers73 159‐161 and even pilots in armed forces, where it has been provided by Governments (Emonson & Vanderbeek, 1995). Amphetamine (AMPT) and methamphetamine (MAMPT) both increase the release of dopamine, noradrenalin, adrenaline and serotonin (Seiden, Sobol, & Ricaurte, 1993; World Health Organization, 2004), stimulate the central nervous system, and have a range of effects including increased energy, feelings of euphoria, decreased appetite, elevated blood pressure and increased heart rate.
    [Show full text]
  • Staging Category Base Rate Article Description HS Heading/ Subheading D
    HS Heading/ SubheadingArticle description Base Rate Staging Category 280110000 - Chlorine 30% D 280120000 - Iodine 10% B 280130000 - Fluorine; bromine 5% A Sulphur, sublimed or precipitated; colloidal 280200000 sulphur. 5% A Carbon (carbon blacks and other forms of 280300000 carbon not elsewhere specified or included). 5% A 280410000 - Hydrogen 10% B 280421000 -- Argon 5% A 280429100 --- Neon 5% A 280429200 --- Helium 5% A 280429900 --- Other 10% B 280430000 - Nitrogen 30% D 280440000 - Oxygen : 30% D 280450000 - Boron; tellurium 10% B -- Containing by weight not less than 99.99 % of 280461000 silicon 10% B 280469000 -- Other 10% B 280470000 - Phosphorus 5% A 280480000 - Arsenic 10% B 280490000 - Selenium 5% A 280511000 -- Sodium 5% A 280519000 -- Other 5% A 280521000 -- Calcium 5% A 280522000 -- Strontium and barium 5% A - Rare-earth metals, scandium and yttrium, 280530000 whether or not intermixed or interalloyed 5% A 280540000 - Mercury 5% A 280610000 - Hydrogen chloride (hydrochloric acid) 30% D 280620000 - Chlorosulphuric acid 5% A 280700000 Sulphuric acid; oleum. 5% A 280800000 Nitric acid; sulphonitric acids. 5% A 280910000 - Diphosphorus pentaoxide 5% A 280920000 - Phosphoric acid and polyphosphoric acids 5% A 281000000 Oxides of boron; boric acids. 5% A 281111000 -- Hydrogen fluoride (hydrofluoric acid) 5% A 281119100 --- Hydrogen cyanide 5% A 281119900 --- Other 5% A 281121000 -- Carbon dioxide 30% D 281122000 -- Silicon dioxide 5% A 281123000 -- Sulphur dioxide 10% B 281129000 -- Other 5% A 281210100 -- Arsenic trichloride 5%
    [Show full text]
  • Idaho State Police Forensic Laboratory Training Manual Cocaine
    Idaho State Police Forensic Laboratory Training Manual Cocaine 1.0.0 HISTORY Archaeological artifacts show that the use of coca was widely accepted in ancient cultures of South American Indians. Paintings on pottery, ornaments depicting pictures and symbols of the coca bush and its leaves, as well as sculptured wood and metal objects dating as far back as 3000 BC on the coast of Ecuador indicate the use of coca in both civil and religious rituals. Relatively recent studies of the antiquity of the use and cultivation of coca indicate that the Servicescoca plant is native to the eastern Andes Mountains. Until this day, the natives in the area continue the custom of chewing coca. A French chemist, Angelo Mariani, introduced Europe to the coca leaf by importing tons of coca leaves and using an extract from them in many products such as his “Coca Wine.” Cocaine, as obtainedForensic fromCopy the coca leaves, was first discovered by Gaedecke in 1855 and rediscovered by Niemann in 1859, at which time he gave the compound the name cocaine. The local anesthetic properties of cocaine were demonstrated first by Wohler in 1860; however, it was not used medically until 1864 as a topical anestheticPolice in the eye. Internet 2.0.0 TAXONOMY DOCUMENT The French botanist JosephState de Jussieu made the first taxonomical reference to coca1 in 1750. He assigned the plants to the genus Erythroxylum. Later, Lamarck, another French botanist, published six new species, including the famous ErythroxylumIdaho coca Lamarck, in 1786. Today, the full taxonomical classificationof is: CATEGORYUncontrolled TAXON OBSOLETE Division (phylum) Spermatophyta Class Dicotyledons (shrubs and trees) PropertyOrder Geraniales Family Erythroxylaceae Genus Erythroxylum Species One Erythroxylum coca Lamarck 1Note that other literature sources seem to credit Patrick Brown as the founder of the genus Erythroxylum (in 1756).
    [Show full text]
  • Tropane the Bicyclic Amine That Is the Precursor to ~ $4 Billion Pharmaceutical Industries QH
    Tropane The bicyclic amine that is the precursor to ~ $4 billion pharmaceutical industries QH Shahjalal University of Science & Technology, Bangladesh. Molecule of the Month – June 2012 What is tropane? Tropane is a bicyclic amine that has a pyrrolidine and a piperidine ring sharing a common nitrogen atom and 2 carbon atoms. It is the common structural element of all tropane alkaloids (Lounasmaa and Tamminen, 1993). Fig. 1 Tropane; (1R, 5S)-8-methyl-8-azabicyclo [3.2.1] octane In what form is it found in nature or used as? Tropane does not occur naturally in free form rather it is found as part of esters in plant species. Esters of tropane are generally secondary metabolites of these plants. Fig. 2 Some natural esters of tropane Almost all of the tropane based pharmaceuticals are natural or semi-synthetic esters. There are also alkylated or arylated tropane-compounds known as phenyltropanes. Fig. 3 Arylated or alkylated tropane (left) and semi-synthetic esters (right) Why is tropane important? Tropane derivatives are among the economically most important pharmaceuticals (Rates 2001; Raskin 2002). Various pharmaceutical industries are manufacturing over 20 active pharmaceutical ingredients (APIs) containing the tropane moiety in their structures; they are applied as mydriatics, antiemetics, antispasmodics, anesthetics, and bronchodilators (Grynkiewicz and Gadzikowska, 2008). Fig. 4 Tropane in APIs, their major applications, and annual global revenue When was its chemistry developed? Although alkaloids with the tropane moiety are the oldest medicines known to man, only recently they have been isolated, purified and studied. K. Mein First to isolate atropine in 1831 P. L. Geiger First to isolate hyoscyamine in 1833 Friedrich Gaedcke First to isolate cocaine in 1855 K.
    [Show full text]
  • Title 21 Food and Drugs Part 1300 to End
    Title 21 Food and Drugs Part 1300 to End Revised as of April 1, 2014 Containing a codification of documents of general applicability and future effect As of April 1, 2014 Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register VerDate Mar<15>2010 11:22 May 06, 2014 Jkt 232078 PO 00000 Frm 00001 Fmt 8091 Sfmt 8091 Y:\SGML\232078.XXX 232078 ehiers on DSK2VPTVN1PROD with CFR U.S. GOVERNMENT OFFICIAL EDITION NOTICE Legal Status and Use of Seals and Logos The seal of the National Archives and Records Administration (NARA) authenticates the Code of Federal Regulations (CFR) as the official codification of Federal regulations established under the Federal Register Act. Under the provisions of 44 U.S.C. 1507, the contents of the CFR, a special edition of the Federal Register, shall be judicially noticed. The CFR is prima facie evidence of the origi- nal documents published in the Federal Register (44 U.S.C. 1510). It is prohibited to use NARA’s official seal and the stylized Code of Federal Regulations logo on any republication of this material without the express, written permission of the Archivist of the United States or the Archivist’s designee. Any person using NARA’s official seals and logos in a manner inconsistent with the provisions of 36 CFR part 1200 is subject to the penalties specified in 18 U.S.C. 506, 701, and 1017. Use of ISBN Prefix This is the Official U.S. Government edition of this publication and is herein identified to certify its authenticity.
    [Show full text]
  • II.2.4 Cocaine and Its Metabolites by Kenichi Takekawa
    2.4 II.2.4 Cocaine and its metabolites by Kenichi Takekawa Introduction Cocaine is an alkaloid being contained in the leaves of Erythroxylon coca Lam. or Erythroxylon novogranatense (Morris) Hieronymus of Erythroxylaceae plants. Th e compound is being used as a local anaesthetic. It also shows stimulating action on the central nervous system; when it is used continuously, psychic dependence on its use appears, resulting in its chronic toxicosis [1]. Cocaine is being abused worldwide; its abuse is most serious in the north and south American continents. Fortunately, in Japan, its abuse is not so many; but it cannot be overlooked. In this chapter, the methods of extractiona and GC/MS analysis for cocaine and its main metabolites, such as ecgonine methyl ester ( EME) and benzoylecgonine ( BE), in urine and blood, are presented; a fatal cocaine poisoning case, which the author experienced, is also demonstrated. Chemical synthesis of the metabolite standards [2] • Cocaine hydrochloride (Shionogi & Co., Ltd., Osaka, Japan; Takeda Chem. Ind. Ltd., Osaka, Japan; or Sigma, St. Louis, MO, USA) is dissolved in 0.2 M hydrochloric acid aqueous solu- tion and heated at 90 °C with refl uxing (gentle mixing) for 24 h to produce ecgonine. Th e solution is extracted with ethyl ether to remove benzoic acid. Th e dried residue of ecgonine hydrochloride is dissolved in 10 % hydrochloric acid methanolic solution for its methyla- tion to synthesize EME [2]. • Aqueous solution of cocaine hydrochloride is carefully adjusted to pH 7 by repeated addi- tion of 0.1 M NaOH solution with refl uxing for 3 days; precipitated BE can be obtained.
    [Show full text]
  • Cat. No. E147 ECGONINE METHYL ESTER-D3 HYDROCHLORIDE HYDRATE 98 ATOM %D--DEA SCHEDULE IILORIDE (N
    Cat. No. e147 ECGONINE METHYL ESTER-D3 HYDROCHLORIDE HYDRATE 98 ATOM %D--DEA SCHEDULE IILORIDE (N- METHYL d3, 98%) Reference standard for cocaine analysis. D3C N Mol. Formula: C10H14D3NO3×HCl COOCH3 H • HCl Mol. Wt.: 238.71 (anhyd.) OH CAS Registry No.: 118357-31-6 H Chemical Name: (–)-3b-Hydroxy -1aH-5aH-tropane-2b-carboxylic acid methyl ester hydrochloride (N-methyl-d3) Physical Properties: Methanol solution containing 0.1 mg/ml. Product supplied in a sealed glass ampoule. When opening the ampoule, gloves and safety goggles are recommended: cover the ampoule with a cloth and place thumbs on the score line; while applying light pressure away from the body, snap the ampoule open. Caution: The pharmacology of this compound is incompletely characterized and due care should be exercised in its use. Avoid skin contact, ingestion or inhalation. Storage: Store the unopened ampoule at -20°C. After opening, transfer to a small tightly sealed vial or other container and store at -20°C. Solubility: Soluble in methanol. Disposal: Dissolve or mix the compound with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. References: 1. Abusada, G.M., Abukhaiaf, I.K., Alford, D.D., Vinzon-Bautista, I., Pramanik, A.K., Ansari, N.A., Manno, J.E., Manno, B.R. “Solid-phase extraction and GC/MS quantitation of cocaine, ecgonine methyl ester, benzoylecgonine, and cocaethylene from meconium, whole blood, and plasma.” J. Anal. Toxicol. 17, 353-358 (1993). 2. Cone, E.J., Hillsgrove, M., Darwin, W.D. “Simultaneous measurement of cocaine, cocaethylene, their metabolites and "crack" pyrolysis products by GC/MS.” Clin.
    [Show full text]
  • Truxiffense Contain 18 Alkaloids, Identified So Far, Belonging to the Tropanes, Pyrrolidines and Pyridines, with Cocaine As the Main Alkaloid
    Journal of Ethnopharmucolo~, 10 (1984) 261-274 261 Elsevier Scientific Publishers Ireland Ltd. Review Paper BIOLOGICAL ACTIVITY OF THE ALKALOIDS OF ERYTHROXYLUM COCA AND ER YTHROXYLUM NOVOG~NATEN~E M. NOV?Ka, C.A. SALEMINKa and I. KHANb aI)epartment of Organic Chemistry of Natural Products, Organic Chemical Laboratory, State ~~~ue~~t~ of Utrecht, Utrecht (The Nether~~) and bIXvision of mental realty, World Health Organization, Geneva (Switzerland) (Accepted February 22nd, 1984) Summary The cultivated Erythroxylum varieties E. coca var. coca, E. coca var. ~~adu, E. no~gra~tense var. ~vo~a~te~~ and E. no~~nate~e var. truxiffense contain 18 alkaloids, identified so far, belonging to the tropanes, pyrrolidines and pyridines, with cocaine as the main alkaloid. The biological activity of the following alkaloids has been reported in the literature: cocaine, cinnamoylcocaine, benzoylecgonine, methylecgonine, pseudo- tropine, benzoyl~opine, tropacocaine, cy- and ~-t~x~~e, hygrine, cusco- hygrine and nicotine. The biological activity of cocaine and nicotine is not reviewed here, because it is discussed elsewhere in the literature. Hardly any- thing is known about the biological activity of the other alkaloids present in the four varieties mentioned. The biosynthesis of the coca alkaloids has been outlined. -- Introduction Historical background Coca leaves have been chewed by the South American Indians to prevent hunger and to increase endurance for over 5000 years. Even today it is used as a stimulant and medicine in many parts of the Andes and in the Amazon basin (Martin, 1970; Plowman, 1979a). The coca shrub is one of the oldest cultivated plants of South America. As recently recognized (Plowman, 1982), the cultivated coca plants belong to two distinct species of the genus E~throxyfum (family E~~roxyla~eae): Eryth~xyium coca Lam.
    [Show full text]